SCHEMBL355401

SCHEMBL355401

COCC(=O)N(C)c1nsc2cccc(OC(F)F)c12

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.34
KDM4E B2RXH2 2/20 0.34
HSD17B10 Q99714 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
CASP1 P29466 1/20 0.33
HCRTR1 O43613 4/20 0.32
HCRTR2 O43614 4/20 0.32
POLB P06746 1/20 0.32
NR1I2 O75469 1/20 0.32
CYP1A2 P05177 1/20 0.31
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.31
PDE4B Q07343 1/20 0.31
RAB9A P51151 2/20 0.31
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10167484 0.89 HCRTR1 (0.35) HPGDKDM4EHSD17B10SMN1; SMN2MEN1
SCHEMBL352205 0.87 HCRTR1 (0.34) HPGDKDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL351412 0.87 PDE4A (0.34) HPGDKDM4EHSD17B10SMN1; SMN2MEN1
SCHEMBL10167481 0.85 HCRTR1 (0.34) SMN1; SMN2KMT2AHCRTR1HCRTR2POLB
SCHEMBL357050 0.82 KDM4E (0.34) HPGDKDM4EHSD17B10SMN1; SMN2MEN1
SCHEMBL10167485 0.82 HCRTR1 (0.33) SMN1; SMN2HCRTR1HCRTR2MAPTALDH1A1
SCHEMBL10167491 0.81 LMNA (0.40) KDM4ESMN1; SMN2MEN1KMT2AHCRTR1
SCHEMBL355455 0.80 ALDH1A1 (0.38) HPGDKDM4EHSD17B10SMN1; SMN2MEN1
SCHEMBL10167486 0.80 HCRTR1 (0.33) HCRTR1HCRTR2MAPTPDE4B
SCHEMBL10167494 0.79 HCRTR1 (0.36) HPGDKDM4EHSD17B10SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2064196-B1 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II BASF SE (DE) 2012-03-14 EP disclosed
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
WO-2008090048-A2 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II BASF SE (DE) 2008-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BPNT1, BCAT1, TGFBR1 HPGD 4749/4885KDM4E 3057/4885HSD17B10 1914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.